Daily Hong Kong Stock Market News Express (Wednesday, May 28)

< br > < b > Stock News < br > < span class = "section-news" > 1. Xiaomi Group (01810.HK): Quarter 1, 2025, Xiaomi Group's total revenue was 111.3 billion yuan, a record high, an increase of 47.4% year-on-year. < br > < span class = "section-news" > 2. Xiaomi Group (01810.HK) Q1 Conference Call: There is no worry about the impact of YU7 on SU7 sales. SU7 does not need to be reduced in price. Future YU7 sales can refer to Model Y. < br > < span class = "section-news" > 3. Zhihu (02390.HK): The net loss of Quarter 1 in 2025 was RMB 10.10 million (US $1.40 million), a decrease of 93.9% from the same period in 2024. < br > < span class = "section-news" > 4. Kuaishou (01024.HK) Net profit in Q1 2025 was 3.979 billion yuan, 4.12 billion yuan in the same period of the previous year, a decrease of 3.4% year-on-year. < br > < span class = "section-news" > 5. 00052.HK: It is expected that the profit attributable to shareholders will decrease by no more than 30%. < br > < span class = "section-news" > 6. Rongchang Bio (09995.HK): Titasepr, a drug for the treatment of systemic myasthenia gravis, has been approved for marketing in China. < br > < span class = "section-news" > 7. Junshi Biosciences (01877.HK): A new indication for Ongoriximab Injection has been approved. < br > < span class = "section-news" > 8. China Biopharmaceutical (01177.HK): The Phase I study data of TQB2102 "HER2 dual antibody ADC" will be announced at the ASCO Annual Meeting in 2025. < br > < span class = "section-news" > 9. China Health Technology Group (01069.HK) recommends "10 in 1" merger. < br > < span class = "section-news" > 10. Meituan (03690.HK) bought back 3.0187 million shares at a cost of HK $392 million on May 27. < br > < span class = "section-news" > 11. Tencent Holdings (00700.HK) bought back 979,000 shares at a cost of HK $500.30 million on May 27.